Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 20,049 shares at $37.91 ($760K) on 2024-01-26, disclosed to the SEC on 2024-01-29.
Open-market sale of $760k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.91 | 9,948 | $377K | 49.6% |
| 2 | $37.91 | 9,948 | $377K | 49.6% |
| 3 | $38.45 | 153 | $6K | 0.8% |
| Total | $37.91 avg | 20,049 | $760K | 100% |
| Filing → |
| IMVT | SELL | 2025-07-25 | $43K | — | Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |